nQ Medical
Kevin Forness is currently the VP Regulatory & Quality at PneumoWave, a company focused on addressing opioid-induced respiratory depression through advanced data analytics. With a background in quality and regulatory consulting services for various industries, Kevin has held management roles at companies such as K2 Management Group, nQ Medical Inc, and QualComp Consulting Services. Kevin also has experience in the wireless communication, medical device manufacturing, and glass manufacturing industries. Kevin holds an MBA in Operations / Supply Chain Management from Saint Louis University and a BS in Chemical Engineering from Missouri University of Science and Technology.
This person is not in any offices
nQ Medical
nQ Medical's artificial intelligence technology has shown in four years of clinical trials at MIT to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders. nQ focuses on the analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders.